InvestorsHub Logo
Followers 7
Posts 754
Boards Moderated 0
Alias Born 07/26/2010

Re: north40000 post# 12889

Thursday, 04/09/2015 8:34:23 AM

Thursday, April 09, 2015 8:34:23 AM

Post# of 40503
Cabilly patents 1, 2, & 3 do not effect the production od Inovio dmabs. In the ebola research Medimmune will be producing the protein mabs and they are a licensee of Genentech's mab technology. Inovio will be produciong the dmab's in this research. Inovio does not use e coli or cho cells...

I would refer you to Inovio's site:

http://www.inovio.com/technology/dna-monoclonal-antibodies/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News